| Date Filed | Type | Description |
| 10/12/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/02/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/31/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/27/2023 |
SC 13G
| EcoR1 Capital, LLC reports a 16.9% stake in Mersana Therapeutics, Inc. |
| 07/18/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/16/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 6.8% stake in Revolution Medicines, Inc. |
| 06/07/2023 |
SC 13G
| EcoR1 Capital, LLC reports a 9.9% stake in Galapagos NV |
| 05/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/02/2023 |
4
| EcoR1 Panacea Holdings II, LLC (10% Owner) has filed a Form 4 on Panacea Acquisition Corp. II|
Txns:
| Disposed/sold 545,000 shares
@ $0 |
|
| 02/14/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 6.7% stake in Galapagos NV |
| 02/14/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 0% stake in Avidity Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 3% stake in 2seventy bio, Inc. |
| 02/14/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 9.1% stake in Hookipa Pharma Inc. |
| 02/14/2023 |
SC 13G
| EcoR1 Capital, LLC reports a 10% stake in Tempest Therapeutics Inc. |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 8.7% stake in Ovid Therapeutics Inc. |
| 02/10/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 0% stake in Akouos, Inc. |
| 02/10/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 7.6% stake in ORIC Pharmaceuticals, Inc. |
| 02/10/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 9.9% stake in Kura Oncology, Inc. |
| 02/10/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 0% stake in Gritstone bio, Inc. |
| 02/10/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 7.4% stake in Atea Pharmaceuticals, Inc. |
| 02/10/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 4.9% stake in Alector, Inc. |
| 01/23/2023 |
4
| EcoR1 Capital, LLC (10% Owner) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Bought 144,100 shares
@ $9.4909, valued at
$1.4M
Bought 163,400 shares
@ $9.8843, valued at
$1.6M
|
|
| 01/23/2023 |
SC 13G
| EcoR1 Capital, LLC reports a 5% stake in Revolution Medicines, Inc. |
| 01/18/2023 |
4
| EcoR1 Capital, LLC (10% Owner) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Bought 342,100 shares
@ $9.806, valued at
$3.4M
Bought 440,000 shares
@ $9.8042, valued at
$4.3M
Bought 203,000 shares
@ $9.9953, valued at
$2M
|
|
| 01/13/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 10% stake in Voyager Therapeutics, Inc. |
| 01/12/2023 |
4
| EcoR1 Capital, LLC (10% Owner) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Bought 920,000 shares
@ $7.6491, valued at
$7M
Bought 106,300 shares
@ $7.8731, valued at
$836.9k
|
|
| 01/11/2023 |
4
| EcoR1 Capital, LLC (10% Owner) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 456,000 shares
@ $7.6717, valued at
$3.5M
Sold 336,400 shares
@ $8.0542, valued at
$2.7M
Sold 110,000 shares
@ $8.4965, valued at
$934.6k
|
|
| 01/09/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 14.7% stake in Graphite Bio, Inc. |
|